As part of its Speaking Out video series, CURE spoke with Juanita Miller, an ANGEL Advocate from the Tigerlily Foundation, about fear of recurrence after breast cancer.
Videos
This program was possible with support from Bayer.
A genitourinary oncologist provides insights on the treatment decision-making process and the roles of guidelines for prostate cancer.
This program was possible with support from Bayer.
An experienced public health and cancer researcher offers advice to patients newly diagnosed with prostate cancer and discusses barriers to access to care.
Merkel cell carcinoma made headlines with the death of Jimmy Buffett. It’s rare and dangerous, and cases are becoming more common.
This program was possible with support from Bayer.
Rashid K. Sayyid, MD, MSc, describes the staging and risk stratification process for patients with prostate cancer and their effect on prognosis.
This program was possible with support from Bayer.
Reginald Tucker-Seeley, MA, ScM, ScD, gives an overview of the screening and diagnosis process of prostate cancer.
Clinical insights on the typical presentation of kidney cancer and the diagnostic process.
Chandler H. Park, MD, and Tian Zhang, MD, MHS, give an overview of renal cell carcinoma (RCC) and outline disease risk factors, symptoms, and prevention strategies.
Tanning beds cause an increased risk of skin cancer among young people — especially those who have a family history of skin cancer.
As part of its Speaking Out video series, CURE spoke with Hannah-Lise Schofield of the Children’s Hospital of Philadelphia about the psychosocial needs of young patients with cancer and their families as well as how those needs change over time.
As part of its Speaking Out video series, CURE spoke with Bruce L. Levine of the University of Pennsylvania Perelman School of Medicine about advancements in treatments for pediatric cancer.
As part of its Speaking Out video series, CURE spoke Bruce L. Levine of the University of Pennsylvania Perelman School of Medicine about CAR-T cell therapy, what it means for young patients with cancer and what new horizons it has revealed for treatment.
As part of its Speaking Out video series, CURE spoke with Tom Whitehead, co-founder and president of the Emily Whitehead Foundation, about the process of seeking treatment and what resources are available for young patients with cancer and their families.
Dr Nour Abahadra of Memorial Sloan Kettering discusses the diagnosis, treatment, and management of metastatic triple negative breast cancer (TNBC). Patient guest, Shay Elkins, shares her experience, from discovering a rapidly growing tumor to navigating her diagnosis and treatment, highlighting the importance of personalized support and resources available online.
A two-time breast cancer survivor who was diagnosed with chronic lymphocytic leukemia in 2020 discussed her belief in the power of minimal residual disease testing.
While the recent approval of a Jemperli-based regimen was an exciting advancement in the endometrial cancer space, racial disparities still exist and need to be addressed, and expert said.
Patients experiencing chemotherapy-related cognitive impairment may forget where they put things or even stop paying their bills, an expert said.
This program was possible with support from Bayer.
Clinical insights on the typical presentation of prostate cancer and how the disease is diagnosed.
This program was possible with support from Bayer.
Alicia Morgans, MD, MPH, reviews the incidence of prostate cancer and risk factors associated with the disease.
As part of its Speaking Out video series, CURE spoke with Nikki Yuill, oncology social worker and director of the Leukemia & Lymphoma Society’s Information Resource Center, about some of the challenges faced by patients.
As part of its Speaking Out video series, CURE spoke with Dr. Lee Greenberger, chief scientific officer of the Leukemia & Lymphoma Society, about the current research in treatments.
As part of its Speaking Out video series, CURE spoke with Dr. Lee Greenberger, chief scientific officer of the Leukemia & Lymphoma Society, who discussed recent treatment advancements and FDA approvals.
As part of its Speaking Out video series, CURE spoke with Nikki Yuill, oncology social worker and director of the Leukemia & Lymphoma Society’s Information Resource Center, about some of the challenges faced by patients.
As part of its Speaking Out video series, CURE spoke with Nikki Yuill, oncology social worker and director of the Leukemia & Lymphoma Society’s Information Resource Center, about some of the challenges faced by patients.
Patients with prostate cancer may have an inherited or acquired BRCA mutation, and both can have treatment implications, an expert said.
Prehabilitation can help patients become eligible for certain cancer treatments, or also help them recover from therapies, while also improving their overall health and fitness, an expert explained.
With multiple therapies available for patients with myeloma, there are some considerations that patients should discuss with their clinicians before choosing which one is right for them, an expert said.
Wearable fitness devices can offer valuable insights for patients with cancer and the doctors treating them.
Artificial intelligence platforms such as ChatGPT are offering patients a more personal and conversational way to research their cancer, an expert said.
In conjunction with Cancer Champions, CURE® recently hosted the “Educated Patient® Webinar: An Overview of Diet and Exercise in Cancer Care."
Advertisement
Advertisement